Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **30S ribosomal subunit of bacteria** is the smaller component of the prokaryotic 70S ribosome. It consists primarily of one molecule of highly conserved **16S rRNA** (~1540 nucleotides) and about **21 proteins**. Its main functions are to bind messenger RNA (**mRNA**) and ensure accurate base-pairing between codons on mRNA and anticodons on transfer RNA (**tRNA**) during translation. This process is essential for correct protein synthesis in all bacteria. The 30S subunit plays a critical role in two steps: *Decoding*: It discriminates against aminoacyl-tRNAs that do not match the codon presented by mRNA, ensuring high fidelity during protein translation. *Translocation*: Together with the large (50S) subunit, it helps move tRNAs and associated mRNAs precisely by one codon at each step. A key feature is its interaction with initiation factors IF‑1, IF‑2, IF‑3 during assembly into an active translation complex. The universally conserved regions within its rRNA—such as residues A1492/A1493—are crucial for monitoring correct base-pairing. The bacterial 30S ribosomal subunit is a major target for several classes of clinically important antibiotics—including aminoglycosides (streptomycin), tetracyclines, spectinomycin—which inhibit bacterial growth by binding to specific sites on this structure and disrupting either decoding accuracy or translocation along the message. These interactions form the basis for many antibacterial therapies. Because it is unique to prokaryotes—and structurally distinct from eukaryotic small ribosomal subunits—the bacterial 30S provides selective toxicity that underpins antibiotic action while sparing human cells.
Inhibition of protein synthesis by interfering with mRNA decoding or translocation on the ribosome; antibiotics bind to the 30S subunit and disrupt its function in translation fidelity or movement along mRNA.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 30S ribosomal subunit of bacteria (30S subunit).